H6: code c19-a review of the manufacturing records indicated the lot met all pre-release manufacturing specifications.As the device was not accessible, the product history review (phr) review was the extend of the investigation.No device problem was found per review of these records.H6: code c20 - the device remains implanted and, therefore, was not available for direct analysis by gore.According to the gore® excluder® aaa endoprosthesis instructions for use, correct pre-treatment planning includes determining the accurate size of the patient¿s anatomy and the proper size of the trunk-ipsilateral endoprosthesis and contralateral endoprostheses.Additionally, adverse events that may occur and/or require intervention include, but are not limited to endoleaks, and occlusion of device or native vessel w.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
On (b)(6) 2023, this patient underwent an endovascular treatment of an abdominal aortic aneurysm using a gore® excluder® conformable aaa endoprosthesis with active control system and gore® excluder® aaa endoprostheses.After all the planned devices were placed, distal type i endoleaks were observed in the left and right common iliac arteries.For the right side, a contralateral leg component was added.For the left side, unplanned embolization of the left internal iliac artery was performed and an additional contralateral leg component was implanted over the left external iliac artery.An angiography revealed the disappearance of type i endoleak.A type ii endoleak remained due to the blood flow from the lumbar artery, but no further treatment was given.The patient tolerated the procedure.The physician stated that the device implanted in the common iliac artery was undersized and that a larger device should have been selected.
|